| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
10,820,000 |
| Market
Cap: |
1.30(B) |
| Last
Volume: |
401,241 |
Avg
Vol: |
400,132 |
| 52
Week Range: |
$115.55 - $119.99 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Heska sells veterinary and animal health diagnostic and specialty products. Co.'s primary focus is on the canine and feline healthcare space. Co.'s business is composed of two segments: North America and International. Co.'s main product categories sold in both segments include: Point of Care laboratory instruments and consumables; digital imaging diagnostic instruments, software and services; digital cytology services; local and cloud-based data services; allergy testing and immunotherapy; and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
14,458 |
| Total Buy Value |
$0 |
$0 |
$0 |
$851,078 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Wisnewski Nancy |
Chief Operating Officer |
• – – |
2020-12-08 |
4 |
S |
$133.03 |
$46,598 |
D/D |
(350) |
46,374 |
|
-22% |
|
| Wisnewski Nancy |
Chief Operating Officer |
• – – |
2020-12-07 |
4 |
S |
$131.00 |
$19,650 |
D/D |
(150) |
46,724 |
|
-32% |
|
| Wilson Kevin S. |
CEO and President |
• • – |
2020-12-01 |
4 |
D |
$123.96 |
$202,179 |
D/D |
(1,631) |
80,943 |
|
- |
|
| Wilson Kevin S. |
CEO and President |
• • – |
2020-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,625 |
82,574 |
|
- |
|
| Aroesty Jason D |
EVP, International Diagnostics |
• – – |
2020-11-27 |
4 |
S |
$126.68 |
$1,691,517 |
D/D |
(13,334) |
0 |
|
-39% |
|
| Aroesty Jason D |
EVP, International Diagnostics |
• – – |
2020-11-27 |
4 |
OE |
$106.67 |
$1,422,338 |
D/D |
13,334 |
13,334 |
|
- |
|
| Wisnewski Nancy |
Chief Operating Officer |
• – – |
2020-11-18 |
4 |
S |
$129.50 |
$64,750 |
D/D |
(500) |
46,874 |
|
-32% |
|
| Antin Robert L |
Director |
– • – |
2020-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
420 |
420 |
|
- |
|
| Wisnewski Nancy |
Chief Operating Officer |
• – – |
2020-11-16 |
4 |
S |
$126.50 |
$126,500 |
D/D |
(1,000) |
47,374 |
|
-32% |
|
| Trowbridge Bonnie J. |
Director |
– • – |
2020-11-09 |
4 |
S |
$124.04 |
$616,959 |
D/D |
(4,917) |
4,089 |
|
-46% |
|
| Trowbridge Bonnie J. |
Director |
– • – |
2020-11-09 |
4 |
OE |
$18.36 |
$165,981 |
D/D |
4,917 |
9,006 |
|
- |
|
| Wilson Kevin S. |
CEO and President |
• • – |
2020-11-03 |
4/A |
D |
$116.41 |
$189,865 |
D/D |
(1,631) |
76,949 |
|
- |
|
| Wilson Kevin S. |
CEO and President |
• • – |
2020-11-03 |
4 |
D |
$116.41 |
$237,593 |
D/D |
(2,041) |
76,539 |
|
- |
|
| Wilson Kevin S. |
CEO and President |
• • – |
2020-11-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,625 |
78,580 |
|
- |
|
| Wilson Kevin S. |
CEO and President |
• • – |
2020-10-21 |
4 |
AS |
$109.00 |
$1,480,037 |
I/I |
(13,421) |
0 |
|
56% |
|
| Wilson Kevin S. |
CEO and President |
• • – |
2020-10-08 |
4 |
AS |
$109.00 |
$341,061 |
I/I |
(3,129) |
3,342 |
|
79% |
|
| Baker Eleanor F. |
EVP, Managing Dir. & COO, scil |
• – – |
2020-09-24 |
4 |
D |
$97.17 |
$26,333 |
D/D |
(271) |
883 |
|
- |
|
| Baker Eleanor F. |
EVP, Managing Dir. & COO, scil |
• – – |
2020-09-24 |
4 |
A |
$0.00 |
$0 |
D/D |
934 |
1,154 |
|
- |
|
| Sveen Christopher D. |
CAO & General Counsel |
• – – |
2020-09-24 |
4 |
A |
$0.00 |
$0 |
D/D |
934 |
948 |
|
- |
|
| Wisnewski Nancy |
Chief Operating Officer |
• – – |
2020-08-31 |
4 |
S |
$103.46 |
$109,065 |
D/D |
(1,050) |
48,374 |
|
-49% |
|
| Davis Stephen L |
Director |
– • – |
2020-08-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
500 |
|
37% |
|
| Davis Stephen L |
Director |
– • – |
2020-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
784 |
784 |
|
- |
|
| Wilson Kevin S. |
CEO and President |
• • – |
2020-08-05 |
4 |
AS |
$107.00 |
$983,032 |
I/I |
(9,176) |
4,088 |
|
37% |
|
| Wilson Kevin S. |
CEO and President |
• • – |
2020-06-05 |
4 |
S |
$91.00 |
$910,000 |
D/D |
(10,000) |
72,955 |
|
-15% |
|
| Wilson Kevin S. |
CEO and President |
• • – |
2020-06-03 |
4 |
S |
$89.00 |
$863,923 |
D/D |
(9,707) |
82,955 |
|
-21% |
|
465 Records found
|
|
Page 5 of 19 |
|
|
